HomeCompareOPORF vs KO

OPORF vs KO: Dividend Comparison 2026

OPORF yields 3.14% · KO yields 2.70%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KO wins by $9.6K in total portfolio value· pulled ahead in Year 5
10 years
OPORF
OPORF
● Live price
3.14%
Share price
$0.09
Annual div
$0.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.5K
Annual income
$384.28
Full OPORF calculator →
KO
The Coca-Cola Company
● Live price
2.70%
Share price
$76.27
Annual div
$2.06
5Y div CAGR
24.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.1K
Annual income
$4,303.79
Full KO calculator →

Portfolio growth — OPORF vs KO

📍 KO pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOPORFKO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OPORF + KO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OPORF pays
KO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OPORF
Annual income on $10K today (after 15% tax)
$266.85/yr
After 10yr DRIP, annual income (after tax)
$326.64/yr
KO
Annual income on $10K today (after 15% tax)
$229.58/yr
After 10yr DRIP, annual income (after tax)
$3,658.22/yr
At 15% tax rate, KO beats the other by $3,331.58/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OPORF + KO for your $10,000?

OPORF: 50%KO: 50%
100% KO50/50100% OPORF
Portfolio after 10yr
$29.3K
Annual income
$2,344.03/yr
Blended yield
8.01%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KO right now

OPORF
No analyst data
Altman Z
3.9
Piotroski
6/9
KO
Analyst Ratings
29
Buy
16
Hold
3
Sell
Consensus: Buy
Price Target
$84.88
+11.3% upside vs current
Range: $81.00 — $88.00
Altman Z
5.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OPORF buys
0
KO buys
0
No recent congressional trades found for OPORF or KO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOPORFKO
Forward yield3.14%2.70%
Annual dividend / share$0.00$2.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%24.3%
Portfolio after 10y$24.5K$34.1K
Annual income after 10y$384.28$4,303.79
Total dividends collected$3.5K$15.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: OPORF vs KO ($10,000, DRIP)

YearOPORF PortfolioOPORF Income/yrKO PortfolioKO Income/yrGap
1$11,014$313.94$10,846$335.73+$168.00OPORF
2$12,108$323.15$11,829$430.64+$279.00OPORF
3$13,288$332.01$12,988$555.50+$300.00OPORF
4$14,558$340.52$14,372$721.34+$186.00OPORF
5← crossover$15,926$348.67$16,049$944.01$123.00KO
6$17,397$356.48$18,114$1,246.74$717.00KO
7$18,979$363.93$20,702$1,664.24$1.7KKO
8$20,679$371.05$24,008$2,249.48$3.3KKO
9$22,504$377.83$28,317$3,085.19$5.8KKO
10$24,464$384.28$34,065$4,303.79$9.6KKO

OPORF vs KO: Complete Analysis 2026

OPORFStock

hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model. In addition, the company is developing a database of infectious disease progression data that include Disease in Motion platform, which comprises unique datasets, such as clinical, immunological, virological, and digital (wearable) biomarkers. The Disease in Motion platform has various potential applications across a range of end users, including big technology, wearables, pharma, and biotech companies. Further, the company provides pre­clinical and early clinical research services; sales and marketing services; and biometry, data management, and statistics to its various European pharmaceutical clients, as well as drug development consultancy and services, including CMC (chemistry, manufacturing, and controls), and PK and medical writing to a range of European clients. The company was formerly known as Open Orphan Plc and changed its name to hVIVO plc in October 2022. hVIVO plc is headquartered in London, the United Kingdom.

Full OPORF Calculator →

KOConsumer Staples

The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide. The company provides sparkling soft drinks, sparkling flavors; water, sports, coffee, and tea; juice, value-added dairy, and plant-based beverages; and other beverages. It also offers beverage concentrates and syrups, as well as fountain syrups to fountain retailers, such as restaurants and convenience stores. The company sells its products under the Coca-Cola, Diet Coke/Coca-Cola Light, Coca-Cola Zero Sugar, caffeine free Diet Coke, Cherry Coke, Fanta Orange, Fanta Zero Orange, Fanta Zero Sugar, Fanta Apple, Sprite, Sprite Zero Sugar, Simply Orange, Simply Apple, Simply Grapefruit, Fresca, Schweppes, Thums Up, Aquarius, Ayataka, BODYARMOR, Ciel, Costa, Dasani, dogadan, FUZE TEA, Georgia, glacéau smartwater, glacéau vitaminwater, Gold Peak, Ice Dew, I LOHAS, Powerade, Topo Chico, AdeS, Del Valle, fairlife, innocent, Minute Maid, and Minute Maid Pulpy brands. It operates through a network of independent bottling partners, distributors, wholesalers, and retailers, as well as through bottling and distribution operators. The company was founded in 1886 and is headquartered in Atlanta, Georgia.

Full KO Calculator →
📬

Get this OPORF vs KO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OPORF vs SCHDOPORF vs JEPIOPORF vs OOPORF vs MAINOPORF vs PEPOPORF vs PGOPORF vs JNJOPORF vs MCD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.